<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
</head>
<body style="background-color:#f6f2ea; color:#361d1e;">
    <h1 style="text-align: center;"><b>Cognitive Enhancement & Human Integration Trial (CEHIT)</b></h1>
    <h4 style="text-align: center;">By accessing or participating in the Cognitive Enhancement & Human Integration Trial (“CEHIT”), you agree to the following terms and conditions (“Agreement”), which govern your involvement in this research program operated jointly by the 
        Neuropath Research Institute and Collins Library.</h4><br><hr><br>
    <h2>Eligibility</h2>
    <h3>Participants must:</h3>
    <ul>
        <li>Be 18 years or older (or possess an alternative age equivalency authorization)</li>
        <li>Have no active illness, injury, physical or mental condition which requires Overnight hospitalization or need of an support (such as service animals or physical disablility support)</li>
        <li>Have read and understood the Participant Information Sheet and Informed Consent Form</li>
        <li>Have no recorded history of irreversible thought entanglement, reality feedback loops, or archive contamination.</li>
    </ul>

    <h2>Voluntary Participation</h2>
    <h3>Participation in the CEHIT study is entirely voluntary. You may:</h3>
    <ul>
        <li>Withdraw from the study at any time without penalty</li>
        <li>Decline to answer any questions or complete any activity that causes discomfort</li>
    </ul>
    <h3>Your decision to participate or not will not affect your access to services at Collins Library or elsewhere.</h3>

    <h2>Nature of the Study</h2>
    <h3>The CEHIT study involves exposure to cognitive training exercises, textual analysis, and sensory perception activities. Study procedures may include:</h3>
    <ul>
        <li>To be tested with the new genetic enginering items</li>
        <li>Engaging with guided reading materials</li>
        <li>Participating in brief, non-invasive monitoring sessions</li>
        <li>Completing questionnaires or psychological assessments</li>
    </ul>

     <h2>Risks and Benefits</h2>
    <h3>The following risks are well recognised, but there may also be risks not included in this list that are
        unforeseen by the doctors.</h3>
        <h3>There may be allergic reactions or infections to the medicines injected unto the physical.</h3>
        <h3>You may develop body aches for 5 days post-injection. </h3>
        <h3>Pain may be associated with this procedure and the healing process.</h3>
        <h3>this study aims to change the human's cognitive mind and physicality and will change you, for the better.</h3>

    <h2>Confidentiality</h2>
    <h3>All information collected will be treated as strictly confidential. Data will be:</h3>
    <ul>
        <li>Anonymized wherever possible</li>
        <li>Stored securely on encrypted servers</li>
        <li>Used solely for research purposes related to this study</li>
    </ul>
    <h3>Your name or identifying details will not be published in any reports or shared with third parties
         without your explicit permission, except as required by law.</h3>

    <h2>Use of Data</h2>
    <h3>By participating, you agree that:</h3>
    <ul>
        <li>Your anonymized data may be used in academic publications or presentations</li>
        <li>Data may be retained for up to 10 years following the conclusion of the study</li>
        <li>Your data will not be sold or used for marketing purposes</li>
    </ul>
    <h3>You may request access to, or the deletion of, your data at any time, subject to legal and regulatory limitations.</h3>

      <h2>Compensation</h2>
    <h3>There is no financial compensation for participation unless otherwise specified in writing.
You may be reimbursed for reasonable travel expenses if pre-approved.</h3>

<h2>Withdrawal and Termination</h2>
<h3>The research team may also end your participation if:</h3>
 <ul>
        <li>You do not meet eligibility requirements</li>
        <li>Continued participation is deemed unsafe for you</li>
        <li>The study is discontinued or altered</li>
    </ul>
<h2>Contact Information</h2>
<h3>If you have questions about your rights as a participant, or wish to file a complaint, you may contact Dr. Layan Tremblay
    through E-mail: l.tremblay@neuropath.institute
</h3>
<i>having read all the terms and conditions, please continue to the form page on the Collins Library website. If you have lost the Page
    click <a href="Project_info.html">here</a> to redirect back to the form.
</i>
</body>
</html>